Picture of Vigil Neuroscience logo

VIGL — Vigil Neuroscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Vigil Neuroscience Announces $40 Million Strategic Investment From Sanofi

June 27 (Reuters) - Vigil Neuroscience Inc  VIGL.O :
    * VIGIL NEUROSCIENCE ANNOUNCES $40 MILLION STRATEGIC
INVESTMENT
FROM SANOFI
    * VIGIL NEUROSCIENCE INC - COMPANY EXPECTS PROCEEDS TO
EXTEND CASH
RUNWAY INTO 2026
    * VIGIL NEUROSCIENCE INC - $40 MILLION STRATEGIC INVESTMENT
IN
COMPANY AT AN AS-CONVERTED PRICE OF $7.44 PER SHARE OF COMMON
STOCK
    * VIGIL NEUROSCIENCE INC - SANOFI TO RECEIVE AN EXCLUSIVE
RIGHT OF
FIRST NEGOTIATION FOR LICENSE OF COMPANY'S SMALL MOLECULE TREM2
AGONIST PROGRAM

Source text for Eikon:  ID:nGNX3WQhDz 
Further company coverage:  VIGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vigil Neuroscience

See all news